1. In vivo relationships between the cerebral pharmacokinetics and pharmacodynamics of thiopentone in sheep after short-term administration

   • Richard N. Upton
   • Guy L. Ludbrook
   • Elke C. Gray

   OriginalPaper 23 February 1996 Pages: 1 - 18

2. The kinetics of continuously infused indocyanine green in the pig

   • Peter Ott
   • Ludvik Bass
   • Susanne Keiding

   OriginalPaper 19 February 1996 Pages: 19 - 44

3. An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs

   • Johannes H. Proost
   • J. Mark K. H. Wierda
   • Dirk K. F. Meijer

   OriginalPaper 30 January 1996 Pages: 45 - 77

4. Multiple solutions, illegal parameter values, local minima of the sum of squares, and anomalous parameter estimates in least-squares fitting of the two-compartment pharmacokinetic model with absorption

   • R. D. Purves

   Pharmacometrics 08 February 1996 Pages: 79 - 101

5. Bayesian individualization via sampling-based methods

   • Jon Wakefield

   Pharmacometrics 01 February 1996 Pages: 103 - 131

6. Towards a practical strategy for assessing individual bioequivalence

   • Robert Schall
   • Roger L. Williams
   • Food and Drug Administration Individual Bioequivalence Working Group

   Commentary 21 February 1996 Pages: 133 - 149

7. Announcements

   Announcement 01 February 1996 Pages: 151 - 152